Aprogen Biologics Inc. (KRX:003060)

Market Cap	115.18B
Revenue (ttm)	68.32B
Net Income (ttm)	-185.40B
Shares Out	197.57M
EPS (ttm)	-969.88
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	356,193
Average Volume	562,362
Open	584.00
Previous Close	583.00
Day's Range	544.00 - 591.00
52-Week Range	520.00 - 1,202.60
Beta	0.06
RSI	50.93
Earnings Date	Nov 13, 2025

About Aprogen Biologics

Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea. It offers approximately 200 types of medicines, including ethical and over the counter drugs. The company offers its drugs for transfusion, digestive system, osteoarthritis, skeletal muscle relaxants, NSAIDs, osteoporosis, circulatory system, endocrine, respiratory system, urinary system, depilatory, antihistamines and antiallergics, obesity, brain function, neurologics, and male pattern hair loss. It also provides anti-biotic, anti-fungal, anti-vira...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1960
• Employees: 391
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003060

Financial Performance

In 2024, Aprogen Biologics's revenue was 67.38 billion, a decrease of -22.88% compared to the previous year's 87.36 billion. Losses were -104.98 billion, -11.24% less than in 2023.